RO5045337

Target: This ligand targets the p53-binding pocket of MDM2 in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for the p53-binding pocket of MDM2. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings the p53-binding pocket of MDM2 into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• PROTAC Design for Degradation: RO5045337 can serve as a ligand module in PROTAC constructs to recruit a specific E3 ligase and drive ubiquitination of the target protein. By pairing RO5045337 with an appropriate E3-binding moiety, researchers can evaluate degradation potency, define optimal linker length, and map structure–activity relationships for efficient targeted protein removal.

• Target Engagement and Turnover: Incorporating RO5045337 into PROTACs enables systematic assessment of target engagement and degradation kinetics. Researchers can compare PROTAC-mediated turnover against non-degrading controls to determine whether RO5045337-based binding supports productive ubiquitin transfer, quantify half-life reduction, and identify conditions that maximize degradation while minimizing off-target effects.

• E3 Ligase Recruitment Optimization: RO5045337-based PROTACs can be used to explore how different E3 ligases influence degradation efficiency. By swapping E3 ligands while keeping the RO5045337 targeting element constant, studies can reveal compatibility with the target’s ubiquitination context, guide selection of the most effective E3 recruiter, and optimize overall PROTAC performance.

• Mechanistic Studies of Ubiquitination: RO5045337-containing PROTACs support mechanistic experiments probing ubiquitination pathways and degradation determinants. Researchers can monitor formation of ternary complexes, assess ubiquitin chain types, and evaluate dependence on proteasome activity, thereby clarifying how RO5045337 positioning and binding translate into robust, pathway-specific targeted protein degradation.

• Cellular Pathway Validation: RO5045337 can be leveraged in PROTAC workflows to validate degradation in relevant cellular models. Researchers can test whether RO5045337-driven recruitment leads to dose- and time-dependent loss of the target, correlate degradation with downstream signaling changes, and use proteomics or rescue experiments to confirm specificity of the targeted degradation mechanism.

RO5045337 is an MDM2-binding ligand scaffold that can guide p53-MDM2 pathway degrader or conjugate design. Linker installation should preserve its hydrophobic aryl recognition features.

Structure: RO5045337 is an MDM2 ligand scaffold containing a substituted imidazoline-like core, two chlorophenyl groups, a tert-butyl/ethoxy aryl region, and a piperazine sulfone side chain. The structure is bulky and hydrophobic but contains polar urea, sulfone, and tertiary amine functionality.

Reactivity: For p53-MDM2 pathway degrader or conjugate design, linker installation should preserve the hydrophobic aryl groups and central MDM2-binding core. The piperazine sulfone side chain is the most plausible solvent-facing region for analog derivatization. Alkyl, PEG, amide, sulfone-compatible, or carbamate linkers may be connected to CRBN, VHL, or IAP ligands, with optimization required to maintain MDM2 binding and avoid excessive molecular weight.